We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biochip Simultaneously Tests for Three Thyroid Hormones

By Labmedica staff writers
Posted on 01 May 2008
Thyroid array biochips simultaneously test for three thyroid hormones in a single sample. More...
The tests are performed an immunoassay analyzer that uses multi-analyte biochip array technology.

The integrated analyzer performs simultaneous quantitative detection of a wide range of protein analytes in a multi-analyte format. Evidence performs multiple immunoassays on each patient sample. The technology platform supports multiple different protein results, per person, on each biochip.

The Evidence immunoassay analyzer is a product of Randox Laboratories (Crumlin, UK). It offers the unique option of reflex reporting. If the thyroid-stimulating hormone (TSH) test result is within the normal range, only the TSH result is reported and the laboratory only pays for one test. If the TSH test result is elevated or low, the thyroxine and tri-iodothyronine test results are automatically reported as well. Reflex reporting offers a number of advantages: only one blood sample is required; the laboratory only performs one test procedure; and the laboratory only pays for the extra thyroid hormone tests when they are required.

TSH is released by the pituitary gland in the brain. Thyroxine (FT4 or TT4) and tri-iodothyronine (FT3 or TT3) are hormones produced by the thyroid gland. TSH is performed as the initial screening test, and all three hormones are essential in the diagnosis of thyroid disease.

The most common thyroid diseases are hyperthyroidism and hypothyroidism, affecting about 2% of the population. In hyperthyroidism, thyroid hormone levels are higher than normal; in hypothyroidism, thyroid hormone levels are low. Other thyroid conditions are goiter and thyroiditis. Thyroid cancer varies between slow-growing tumors with a good prognosis, to aggressive tumors with limited treatment options. Thyroid problems are about 10 times more common in women than in men.

Randox is an international diagnostics company that develops, manufactures, and markets clinical diagnostic products worldwide. Core products are: biochip array technology; clinical chemistry analyzers and reagents; quality controls and European quality assurance (EQA); environmental diagnostics; recombinant proteins and antibodies.


Related Links:
Randox

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.